Top Trending

Serum Institute

COVID-19 / Covovax Vaccine trial for children below 18 age group begins in Pune
Covovax Vaccine trial for children below 18 age group begins in Pune
SII to deliver 1.5 crore vaccine doses to Maharashtra after May 20: Tope
Vaccine / sSII to deliver 1.5 crore vaccine doses to Maharashtra after May 20: Tope
Covishield vaccine's price for states reduced from ₹400 to ₹300 per dose
Vaccine / sCovishield vaccine's price for states reduced from ₹400 to ₹300 per dose
We understand India's needs: US after Poonawalla's tweet to Biden for raw material
USA / sWe understand India's needs: US after Poonawalla's tweet to Biden for raw material
Novavax COVID-19 vaccine 89% effective in UK trial, to be made in India by SII
India / sNovavax COVID-19 vaccine 89% effective in UK trial, to be made in India by SII
SII announces ₹25-lakh compensation for families of those who died in fire
India / SII announces ₹25-lakh compensation for families of those who died in fire
5 dead in fire at coronavirus vaccine maker Serum Institute of India's plant
India / 5 dead in fire at coronavirus vaccine maker Serum Institute of India's plant
Covishield, Covaxin vaccines approved for restricted use in emergency situation in India
India / Covishield, Covaxin vaccines approved for restricted use in emergency situation in India
India 1st priority for COVID-19 vaccine delivery: Serum Institute
India / India 1st priority for COVID-19 vaccine delivery: Serum Institute
Oxford COVID-19 vaccine 70% effective, being made in India by Serum Institute
India / Oxford COVID-19 vaccine 70% effective, being made in India by Serum Institute
General public will have to pay ₹500-600 for Oxford vaccine: Adar Poonawalla
India / General public will have to pay ₹500-600 for Oxford vaccine: Adar Poonawalla
COVID-19 vaccine could be available by January, will be affordable: Poonawalla
India / COVID-19 vaccine could be available by January, will be affordable: Poonawalla

Serum Institute

Please wait loading

SUBSCRIBE TO OUR NEWSLETTER